CTNM
Contineum Therapeutics, Inc.
12.50$
-6.6%
vs. previous close
Closing price · As of: Sep 23, 2026
Statements
Balance Sheet
All figures as a percentage of total assets in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 99.0% | 95.6% | 97.9% | 97.0% | 96.8% | |
| 6.6% | 11.0% | 11.9% | 10.3% | 27.3% | |
| 97.9% | 93.3% | 96.0% | 96.2% | 95.0% | |
| 12.7% | 22.4% | 152.1% | 6.9% | 5.7% | |
| 5.2% | 14.9% | 4.2% | 4.7% | 3.5% | |
| 1.8% | 10.0% | 0.4% | 0.7% | 0.8% | |
| 0.9% | 0.8% | 0.5% | 0.9% | 0.4% | |
| 5.2% | – | – | – | – | |
| 87.3% | 77.6% | -52.1% | 93.1% | 94.3% | |
| -104.4% | -193.3% | -57.6% | -55.2% | -64.1% | |
| 35.6% | 49.6% | 19.3% | 12.1% | 10.0% |
Data as of: September 23, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.